269 related articles for article (PubMed ID: 32214850)
1. LncRNA MALAT1 Regulates the Cell Proliferation and Cisplatin Resistance in Gastric Cancer via PI3K/AKT Pathway.
Dai Q; Zhang T; Li C
Cancer Manag Res; 2020; 12():1929-1939. PubMed ID: 32214850
[TBL] [Abstract][Full Text] [Related]
2. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
3. LncRNA UCA1 promotes cisplatin resistance in gastric cancer via recruiting EZH2 and activating PI3K/AKT pathway.
Dai Q; Zhang T; Pan J; Li C
J Cancer; 2020; 11(13):3882-3892. PubMed ID: 32328192
[No Abstract] [Full Text] [Related]
4. LncRNA MALAT1 expression inhibition suppresses tongue squamous cell carcinoma proliferation, migration and invasion by inactivating PI3K/Akt pathway and downregulating MMP-9 expression.
Yuan J; Xu XJ; Lin Y; Chen QY; Sun WJ; Tang L; Liang QX
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):198-206. PubMed ID: 30657561
[TBL] [Abstract][Full Text] [Related]
5. Propofol facilitates cisplatin sensitivity via lncRNA MALAT1/miR-30e/ATG5 axis through suppressing autophagy in gastric cancer.
Zhang YF; Li CS; Zhou Y; Lu XH
Life Sci; 2020 Mar; 244():117280. PubMed ID: 31926239
[TBL] [Abstract][Full Text] [Related]
6. lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p.
Zhang Z; Li M; Zhang Z
Onco Targets Ther; 2020; 13():1343-1354. PubMed ID: 32104001
[TBL] [Abstract][Full Text] [Related]
7. MALAT1 promotes cisplatin resistance in cervical cancer by activating the PI3K/AKT pathway.
Wang N; Hou MS; Zhan Y; Shen XB; Xue HY
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7653-7659. PubMed ID: 30536307
[TBL] [Abstract][Full Text] [Related]
8. [FJX1 overexpression is associated with poor prognosis and promotes gastric cancer proliferation
Zhang H; Zhang Z; Wang Q; Wang L; Yang Z; Geng Z; Wang Y; Li J; Zuo L
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):975-984. PubMed ID: 37439170
[TBL] [Abstract][Full Text] [Related]
9. [High expression of CPNE3 correlates with poor long-term prognosis of gastric cancer by inhibiting cell apoptosis
Duan T; Zhang Z; Shi J; Xiao L; Yang J; Yin L; Zhang X; Geng Z; Lu G
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):129-137. PubMed ID: 38293984
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol inhibits the proliferation, invasion, and migration, and induces the apoptosis of human gastric cancer cells through the
Yang Z; Xia L
J Gastrointest Oncol; 2022 Jun; 13(3):985-996. PubMed ID: 35837196
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA metastasis-associated lung adenocarcinoma transcript 1 regulates the expression of Gli2 by miR-202 to strengthen gastric cancer progression.
Zhang Y; Chen Z; Li MJ; Guo HY; Jing NC
Biomed Pharmacother; 2017 Jan; 85():264-271. PubMed ID: 27887846
[TBL] [Abstract][Full Text] [Related]
12. lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K/AKT pathway.
Zhu K; Ren Q; Zhao Y
Oncol Lett; 2019 Jun; 17(6):5335-5342. PubMed ID: 31186750
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MALAT1 affects high glucose-induced endothelial cell proliferation, apoptosis, migration and angiogenesis by regulating the PI3K/Akt signaling pathway.
Zhang SH; Zhang SG; Zhou P; Wei X; Mao XD; Lin SG; Liu C
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8551-8559. PubMed ID: 31646587
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA XLOC_006753 Promotes the Development of Multidrug Resistance in Gastric Cancer Cells Through the PI3K/AKT/mTOR Signaling Pathway.
Zeng L; Liao Q; Zou Z; Wen Y; Wang J; Liu C; He Q; Weng N; Zeng J; Tang H; Fang R; Lei Z; Tang Z; Yang X; Cui S
Cell Physiol Biochem; 2018; 51(3):1221-1236. PubMed ID: 30481766
[TBL] [Abstract][Full Text] [Related]
15. LncRNA MALAT1 potentiates autophagy‑associated cisplatin resistance by regulating the microRNA‑30b/autophagy‑related gene 5 axis in gastric cancer.
Xi Z; Si J; Nan J
Int J Oncol; 2019 Jan; 54(1):239-248. PubMed ID: 30365113
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA MALAT1 promotes cholangiocarcinoma cell proliferation and invasion by activating PI3K/Akt pathway.
Wang C; Mao ZP; Wang L; Wu GH; Zhang FH; Wang DY; Shi JL
Neoplasma; 2017; 64(5):725-731. PubMed ID: 28592124
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of ASF1B inhibits cell proliferation, migration, invasion and cisplatin resistance in gastric cancer through the Myc pathway.
Zhang Z; Ning M; Li L; Li Z; Wang Y; Zhao J
Oncol Lett; 2023 Jun; 25(6):242. PubMed ID: 37153049
[TBL] [Abstract][Full Text] [Related]
18. The Human RNA Surveillance Factor UPF1 Modulates Gastric Cancer Progression by Targeting Long Non-Coding RNA MALAT1.
Li L; Geng Y; Feng R; Zhu Q; Miao B; Cao J; Fei S
Cell Physiol Biochem; 2017; 42(6):2194-2206. PubMed ID: 28942451
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of the long non-coding RNA
Yao L; Ye PC; Tan W; Luo YJ; Xiang WP; Liu ZL; Fu ZM; Lu F; Tang LH; Xiao JW
World J Gastrointest Oncol; 2020 Nov; 12(11):1237-1254. PubMed ID: 33250958
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG5 promotes cisplatin resistance in gastric cancer via inhibiting cell apoptosis.
Li M; Zhang YY; Shang J; Xu YD
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4185-4191. PubMed ID: 31173289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
